In Difficult Times For AAV Gene Therapies, AbbVie Boosts Regenxbio’s Ambitions

Wet AMD Is Challenging Target

Regenxbio
• Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D